Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1426119 | Journal of Controlled Release | 2009 | 7 Pages |
Myocardial infarction causes a high rate of morbidity and mortality worldwide, and heat shock proteins as molecular chaperones have been attractive targets for protecting cardiomyoblasts under environmental stimuli. In this study, in order to enhance the penetration of heat shock protein 27 (HSP27) across cell membranes, we fused HSP27 with transcriptional activator (TAT) derived from human immunodeficiency virus (HIV) as a protein transduction domain (PTD). We loaded the fusion protein (TAT-HSP27) into microsphere/hydrogel combination delivery systems to control the release behavior for prolonged time periods. We found that the release behavior of TAT-HSP27 was able to be controlled by varying the ratio of PLGA microspheres and alginate hydrogels. Indeed, the released fusion protein maintained its bioactivity and could recover the proliferation of cardiomyoblasts cultured under hypoxic conditions. This approach to controlling the release behavior of TAT-HSP27 using microsphere/hydrogel combination delivery systems may be useful for treating myocardial infarction in a minimally invasive manner.
Graphical abstractThe release behavior of TAT-HSP27 from microsphere/hydrogel combination systems was controlled over time, and the released protein was useful to recover the proliferation of cardiomyoblasts under hypoxic conditions.Figure optionsDownload full-size imageDownload as PowerPoint slide